BPA Call HT001420A0020-HT009025FG010026
Award Date
1/8/25
Potential Completion Date
9/30/25
Potential Value
$22K
Federal Agency
Defense Health Agency
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6506 - Blood And Blood Products
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Princeton, NJ, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded a $1,006,278.50 firm fixed-price purchase order contract to Sun Pharmaceutical Industries, Inc. for the provision of nuclear medicine imaging products. These products are used for myocardial infarct imaging, diagnostic imaging of gall bladder disorders, and breast cancer nodule imaging. The contract period of performance runs from March 2022 through March 2026. Sun Pharmaceutical Industries, Inc. is a for-profit organization and manufacturer of goods that...
This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract, worth up to $80,000.00, is for the delivery of various radiopharmaceuticals to military treatment facilities to support nuclear medicine diagnostic services for active duty...
This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc. The $75,000 contract is for the delivery of radiopharmaceuticals and supplies to support nuclear medicine diagnostic services for the Military Health System, which provides care to over 9.5 million active duty personnel and their families. Pharmalucence, Inc. is a specialty pharmaceutical manufacturer that has...
This contract award to Lantheus Medical Imaging, Inc. is a Blanket Purchase Agreement (BPA) call from the Defense Health Agency (DHA) for the delivery of radiopharmaceuticals. The contract has a ceiling value of $15,000.00 and a completion date of September 30, 2024. It is a firm fixed-price contract for the provision of critical nuclear medicine supplies and diagnostic imaging agents, primarily used in medical imaging procedures at military treatment facilities, VA medical centers, and other...
The Department of Defense's Defense Health Agency (DHA) awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call order to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $157,041.40 contract is for the delivery of four (4) treatment radiopharmaceutical LUTATHERA, a targeted radioligand therapy used for cancer treatment and diagnostic imaging. This order is part of a larger $26 million...
This is a $150,000 Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Curium US LLC, a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract provides firm fixed price deliveries of various radiopharmaceutical products and services to support healthcare operations at military medical facilities, including Walter Reed National Military Medical Center. The contract has a period of performance through September 30, 2025 and no set-aside...
This federal contract award, valued at $250,000.00, was issued by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The contract covers the provision of various radiopharmaceuticals, with a period of performance through September 30, 2024. This award is part of a larger Blanket Purchase Agreement (BPA) that Lantheus Medical Imaging holds with the DHA, valued at $6.5 million and...
This firm fixed price Blanket Purchase Agreement (BPA) call award from the Defense Health Agency is for 123 DATSCAN services to diagnose imaging agents and radio-pharmaceuticals that can help with a Parkinsonian syndrome diagnosis. The contract has a potential value of $0.00 and performance will occur in Bethesda, Maryland. Medi-Physics, Inc. is the prime contractor selected to deliver the requested diagnosing services under this BPA call contract awarded on February 7, 2019 and completing on...
This firm fixed-price purchase order for $124,815.00 was awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract is for the delivery of SC05 Sulfur Colloid 5 vials/box to support nuclear medicine diagnostic services for active duty personnel and their families within the Military Health System. Pharmalucence, Inc. has been awarded multiple...
Medi-Physics, Inc., a subsidiary of General Electric Company, has been awarded a $55,000 firm fixed price blanket purchase agreement call contract by the Defense Health Agency to provide radiopharmaceuticals and supplies. The contract facilitates the delivery of imaging agents to support nuclear medicine services at Walter Reed National Military Medical Center and other Defense Health Agency facilities through September 30, 2023. As a manufacturer and supplier of medical isotopes and...